Interesting reads ... October 2024
This month’s studies examine the growing role of AI and wearables in healthcare, highlighting gains in efficiency, personalized care, and cost reduction, though challenges with integration persist. Key safety concerns include AI reliability and ethics, particularly with large language models, while diagnostic radiology benefits from AI’s precision despite dataset limitations. European healthcare systems are encouraged to reform, addressing workforce shortages with university hospitals leading innovation. The FDA’s updated risk-based AI framework aims to balance safety and innovation. Concerns are raised about the burden on clinicians to manage AI without adequate training, while research on patient satisfaction finds that AI responses are valued for detail, though clinician empathy remains essential. New datasets and decision support tools in reproductive technology and early warning systems demonstrate promise, underscoring the need for transparency, regulatory oversight, and standardized validation.
Perry LaBoone, PE, CPA, PMP and Oge Marques explore the potential of wearables and AI to transform healthcare by improving efficiency, personalizing patient care, and lowering costs. Their study highlights the rapid adoption of digital health solutions, such as the IoMT, and addresses the integration challenges that must be resolved to optimize patient monitoring, diagnostic accuracy, and healthcare workflow automation.
Wang X, Zhang NX, et al. identify key safety risks in integrating AI into clinical medicine, including issues with reliability, ethical alignment, and the challenges posed by LLMs. They recommend standardized data practices, inclusive training datasets, real-time fact-checking, and stronger clinician-AI interaction models to address these risks and enhance model generalizability, accuracy, and ethical integrity in diverse healthcare settings.
Benjamin York, Sanaz Katal, and Ali Gholamrezanezhad examine the promise and practical challenges of integrating AI into diagnostic radiology, noting both the gains in diagnostic precision and efficiency and the obstacles, such as dataset limitations and context gaps that impair real-world applicability. They recommend strategies like multimodal AI models, natural language processing, and collaborative efforts between radiologists and developers to ensure AI tools are reliable, contextually informed, and clinically beneficial.
The European University Hospital Alliance (EUHA) highlights an urgent need for healthcare reform across Europe to address workforce shortages, rising care demands, and financial constraints impacting system sustainability. The alliance argues that university hospitals should lead these efforts by fostering innovation, enhancing collaboration with EU policy frameworks, and integrating health and social care to create resilient, efficient, and preventative healthcare systems.
Haider Warraich, Troy Tazbaz, and Robert Califf review the FDA’s evolving regulatory approach for AI in healthcare, emphasizing a risk-based framework and ongoing life cycle management to balance innovation with safety. They highlight the necessity of collaboration across sectors and transparent development practices to manage the unique risks posed by advanced AI tools, including large language models, especially in clinical contexts where patient safety and unbiased outcomes are crucial.
Roanne van Voorst, Ph.D. discusses the unrealistic expectations placed on healthcare professionals to oversee AI systems effectively, given their lack of training in computational fields and the complexity of these technologies. The commentary argues that requiring doctors and nurses to become digitally literate adds strain without significantly reducing workloads, as managing AI outputs often introduces new tasks rather than alleviating them, potentially detracting from traditional patient care skills.
Jiyeong (Jasmine) Kim, Michael L. Chen, Shawheen R., April Liang, Susan M. Seav, Dr Sonia Onyeka, Julie J. Lee, Shivam Vedak MD, MBA, David Mui, MD MBA, Rayhan A. Lal, Michael Pfeffer, Christopher Sharp, Natalie Pageler MD, Steve Asch, and Eleni Linos examined patient satisfaction with AI-generated responses versus clinician responses to medical inquiries, finding that AI responses yielded higher satisfaction, especially in cardiology, due to their length and detail. However, clinicians’ longer responses positively impacted satisfaction more distinctly, particularly in cardiology, indicating that while AI's response quality was valued, clinician insights on information quality and empathy were especially appreciated in areas like endocrinology.
João Matos, Shan Chen, Siena Placino, Yingya Li, Juan Carlos Climent Pardo, Daphna Idan, Takeshi Tohyama, David Restrepo, Luis Nakayama, Jose M. M. Pascual-Leone, Guergana Savova, Hugo Aerts, Leo Anthony Celi, A. Ian Wong, MD, PhD, Danielle Bitterman, and Jack Gallifant introduce WorldMedQA-V, a multilingual, multimodal dataset that includes clinically validated exam questions and medical images in four languages, designed to evaluate vision-language models (VLMs) in healthcare. Their findings reveal that VLMs generally perform better with image input, with GPT-4 achieving the highest accuracy and consistency across languages, though limitations include the dataset's size, geographic scope, and complexity representation.
Carlo Bulletti, Jason Franasiak, MD, FACOG, HCLD ALD (ABB), Andrea Busnelli, Romualdo Sciorio, Marco Berrettini, Lusine Aghajanova, Francesco M. Bulletti, and Baris Ata conducted a systematic review that identified 11 clinical decision support algorithms and AI tools potentially beneficial in assisted reproductive technology, particularly in areas like patient counseling, ovarian response prediction, and embryo assessment. While these digital tools show promise in enhancing IVF outcomes and personalizing treatment, the study underscores the need for standardized validation to ensure reliability and integration in clinical practice.
Dana P. Edelson, MD, MS, Matthew Churpek, Kyle A. Carey, Zhenqui Lin, Chenxi Huang, Jonathan M. Siner, Jennifer Johnson, MSN, APRN, PMP, Harlan Krumholz, and Deborah J. Rhodes compared the effectiveness of AI-based and non-AI early warning scores in detecting clinical deterioration in hospital settings. Their findings indicate that while AI-based models generally achieve higher accuracy and provide longer intervention lead times, some non-AI models performed comparably or even better in certain cases, underscoring the need for transparency and regulatory oversight in early warning tool deployment.
Global Legal & Compliance leader with deep pharmaceutical industry experience and a passion for data, technology, AI, and innovation
1moGreat list of articles, thank you for sharing!
Physician Leader | AI in Healthcare | Neonatal Critical Care | Quality Improvement | Patient Safety | Co-Founder NeoMIND-AI and Clinical Leaders Group
1moThanks, great compilation of insight with a broad range across innovation obstacles in healthcare
Trilingual advocate succeeding in hi-profile/complex Public Policy files | #AIinHealthcare 🏥 | Life Sciences 💊 | Government Affairs 🏛️ | Patients-Seniors Advocacy 😷 | Writing ✍️ | Spokesperson 🗣️ | Moderator-MC 🎤 |
1moAh ... a Saturday deep dive of #healthcareinnovation reading. Thank you for your curation of this material.
Re-Thinking the Future of #Healthcare | #Prevention | #Longevity. Helping health business owners find their sweet spot. Health data/software/wearable expert. Follow for posts on health innovation & business.
1mothank you for sharing your insights and recognizing the hard work of researchers!